Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » New Approach Shows Promise in Treating Parkinson’s Symptoms
Disease Discoveries

New Approach Shows Promise in Treating Parkinson’s Symptoms

By Michelle MohneyAug 21, 2019
Share
Facebook Twitter Email
Mark Bevan, PhD, professor of Physiology, was the senior author of the study that showed promise in treating Parkinson’s disease symptoms by restoring the intrinsic discharge of nerve cells within the subthalamic nucleus.

In a study published in Cell Reports, Northwestern Medicine scientists rescued movement in a mouse model of Parkinson’s disease by restoring the intrinsic discharge of nerve cells within the subthalamic nucleus (STN), which is a component of the basal ganglia, a brain network critical for motor and impulse control.

In Parkinson’s disease, degeneration of dopamine-producing neurons in the brain causes the basal ganglia to develop abnormal, synchronized activity, which results in impaired motor function.

“We first determined the mechanisms that cause STN neurons to adapt to the loss of dopamine by slowing their autonomous pacemaking activity,” explained first author Eileen McIver, PhD, a medical writer and recent graduate of the Northwestern University Interdepartmental Neuroscience (NUIN) program.

The scientists found that elevated activity of the “indirect pathway” of the basal ganglia led to increased activation of STN glutamate receptors and ATP-sensitive potassium ion channels, which ultimately reduced autonomous firing. Furthermore, restoring this intrinsic activity with Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) rescued motor function in a mouse model of Parkinson’s disease.

“Within ten minutes of injecting the designer drug to activate DREADDs in the STN, we saw a symptomatic improvement,” explained McIver.

“Our findings provide proof-of-concept for the use of tools like DREADDs as a therapeutic approach in Parkinson’s disease,” said McIver.

Mark Bevan, PhD, professor of Physiology, senior study author and McIver’s graduate advisor, commented, “Autonomous firing underlies the resting output of STN neurons and regulates their response to synaptic input. Dr. McIver’s study argues that the loss of this intrinsic activity promotes abnormal synchronization and motor dysfunction in Parkinson’s disease.”

Additional Northwestern study authors include D. James Surmeier, PhD, Nathan Smith Davis professor and chair of Physiology; David Wokosin, PhD, research associate professor of Physiology; Jeremy Atherton, PhD, and Jyothisri Kondapalli, PhD, research assistant professors of Physiology; and Hong-Yuan Chu, PhD, and Kathleen Cosgrove, PhD, postdoctoral fellows.

The study was supported by National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) grants 2R37 NS041280, P50 NS047085, 5T32 NS041234 and F31 NS090845. Confocal imaging work was performed at the Northwestern Center for Advanced Microscopy, supported by National Cancer Institute (NCI) Cancer Center Support Grant (CCSG) grant P30 CA060553.

Neurology and Neuroscience Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.